Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elazer Edelman | M | 67 |
Alxerion Biotech Corp.
 Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
| Ignacio Plaza | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
| Andrés Vilella Weisz | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
| Steven A. Hite | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mercedes Balcells | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Javier Pedreno
- Personal Network
